Franklin Resources Inc. Has $5.27 Million Stake in The Cooper Companies, Inc. (NASDAQ:COO)

Franklin Resources Inc. increased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 194.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 48,892 shares of the medical device company's stock after acquiring an additional 32,260 shares during the period. Franklin Resources Inc.'s holdings in Cooper Companies were worth $5,265,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Point72 Asset Management L.P. increased its stake in shares of Cooper Companies by 480.1% during the 2nd quarter. Point72 Asset Management L.P. now owns 937,806 shares of the medical device company's stock worth $81,870,000 after purchasing an additional 776,140 shares during the last quarter. Victory Capital Management Inc. increased its position in Cooper Companies by 23.0% during the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company's stock worth $435,856,000 after buying an additional 737,726 shares during the last quarter. Magnetar Financial LLC bought a new position in Cooper Companies during the second quarter valued at about $63,822,000. TD Asset Management Inc acquired a new stake in shares of Cooper Companies in the second quarter worth about $53,045,000. Finally, Impax Asset Management Group plc boosted its stake in shares of Cooper Companies by 31.0% during the 2nd quarter. Impax Asset Management Group plc now owns 2,359,798 shares of the medical device company's stock worth $205,511,000 after acquiring an additional 558,886 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company's stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on COO shares. Piper Sandler boosted their target price on Cooper Companies from $115.00 to $120.00 and gave the stock an "overweight" rating in a report on Thursday, August 29th. Morgan Stanley decreased their price objective on shares of Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating for the company in a report on Friday, December 6th. Stifel Nicolaus reiterated a "buy" rating and issued a $115.00 target price (up previously from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Citigroup decreased their price target on shares of Cooper Companies from $116.00 to $115.00 and set a "buy" rating for the company in a report on Friday, December 6th. Finally, StockNews.com lowered Cooper Companies from a "buy" rating to a "hold" rating in a research note on Wednesday, December 11th. Four equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to MarketBeat, Cooper Companies currently has a consensus rating of "Moderate Buy" and an average price target of $117.00.

Cooper Companies Stock Performance

Shares of NASDAQ COO traded up $0.29 during trading hours on Tuesday, reaching $92.81. The stock had a trading volume of 451,163 shares, compared to its average volume of 1,176,626. The company has a market cap of $18.52 billion, a price-to-earnings ratio of 47.60, a PEG ratio of 2.52 and a beta of 0.97. The Cooper Companies, Inc. has a twelve month low of $84.76 and a twelve month high of $112.38. The business's fifty day moving average is $101.58 and its two-hundred day moving average is $98.93. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $1.03 billion. During the same quarter in the prior year, the company posted $0.87 EPS. The business's revenue was up 9.8% on a year-over-year basis. As a group, research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.